Sexual Dysfunction in Iranian Men with Diabetes; a Systematic Review and Meta-analysis by Abedi, Amir Reza et al.
Men’s Health Journal. 2021; 5(1): e11
REVIEW ARTICLE
Sexual Dysfunction in Iranian Men with Diabetes; a Sys-
tematic Review and Meta-Analysis
Amir Reza Abedi1, Fereshteh Aliakbari2, Mahsa Mirzababaei3, Fereshteh Safian4, Ehsan Shojaeefar2∗
1. Urology department, Shohada Tajrish Hospital, Shahid Beheshti University of Medical Science, Tehran, Iran.
2. Men’s Health and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
3. Department of Midwifery, School of Nursing and Midwifery, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
4. Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Received: January 2021; Accepted: January 2021; Published online: February 2021
Abstract: Introduction: The typical sexual function involves the integrity and harmonious interaction of psychological,
endocrine, vascular, and nervous systems. We aimed to determine the prevalence of sexual dysfunction (SD),
more specifically erectile dysfunction in Iranian men with diabetes. Method: Using keywords including: “sexual
function,” “erectile dysfunction,” “diabetes,” and “Iran”, an electronic search was done on national and inter-
national databases. All cross-sectional or baseline data in cohort studies were included. The prevalence of SD
and its related risk factors were extracted and summarized. The random effect model was used for estimating
the pooled prevalence. Result: Ultimately, 16 studies were included in the qualitative synthesis, amongst which
6 were included for quantitative synthesis. The pooled prevalence of SD across included studies was 50.7%.
with a total sample size of 1513. Two main correlated factors with SD were advanced age and depression. Con-
clusion: Our analysis showed that more than half of the Iranian men with diabetes suffer from SD. Apart from
advanced age, the most important attributes for comorbidity of diabetes and SD in these patients were found to
be chronic uncontrolled high blood sugar and depression. More advanced epidemiological studies are needed
to assess the temporality of the relationship between SD and its related comorbidities and to develop proper
preventive programs.
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1. Introduction
The typical sexual function involves the integrity and harmo-
nious interaction of psychological, endocrine, vascular, and
nervous systems [1]. These systems are susceptible to dis-
ruption from health-related lifestyle choices [2, 3]. Healthy
sexuality is an integral part of human life and can undoubt-
edly lead to social and rational aspects and create relation-
ships and love [4]. Therefore, any disorder leading to incon-
sistency and lack of sexual satisfaction can cause sexual dys-
function (SD)[5]. SD is seen as a universal health problem
for both men and women and can adversely affect the qual-
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ity of life of millions of partners. Most of them prefer to suffer
in silence [6]. However, SD refers to the common and per-
sistent problems associated with divorce and a lower quality
of life, and causes physical, social, and mental health prob-
lems such as mental illness, anxiety, and self-esteem in suf-
ferers and their partners [7]. SD is primarily assessed on the
basis of several SDs such as: erectile dysfunction (ED), ejac-
ulatory disorder, and decreased sexual desire in men, each
leading to increased psychological and social effects of the
disease [8]. The most common sexual complaint in male sex-
ual medicine is erectile ED [9], which is defined as a constant
or recurrent inability (more than six months) to achieve or
maintain an erection sufficient to be followed by satisfactory
sexual activity [10]. ED primarily affects men older than 40
years (with prevalence rates increasing across the adult lifes-
pan)[1]. In addition, the global prevalence of ED is expected
to rise to 322 million cases by 2025 [11]. The pathophysio-
This open-access article distributed under the terms of the Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0).
Downloaded from: www.jmp.iums.ac.ir
A R. Abedi et al. 2
logical source of the disorder can be modifiable risk factors
such as obesity, smoking, stress, depression, and chronic dis-
eases (diabetes, cardiovascular disease, hepatitis, kidney fail-
ure) that have been included as risk factors that affect various
aspects of SD, and are especially influential in the develop-
ment of ED[12-14].
Diabetes is considered to be one of the most critical, sys-
temic, and silent epidemic diseases affecting older adults
worldwide, especially in developing countries such as Asia
[15, 16]. Diabetes is known as a group of endocrine and
metabolic disorders characterized by high blood sugar and
increasing trends around the world. Overall, hyperglycemia
in diabetics can lead to both short- and long-term complica-
tions. One of the long-term complications is SD. It is usually
a disorder that occurs in both male and female patients[17,
18]. Although, SD, especially ED, which is occasionally a chief
complaint in men with diabetes compared with those free
from it, especially in men affected with diabetic vasculopathy
and neuropathy [19, 20]. The pathogenesis of diabetic ED is
widespread and various factors known to increase the risk of
ED in men with diabetes include duration, type, diabetes sta-
tus, blood sugar control, metabolic control, and mental dis-
orders such as depression and anxiety [21-24]. In terms of
the impact on quality of life, early diagnosis and treatment of
ED in these men is essential and could help better manage
and prevent or delay its progression. The high overall SD rate
in diabetics has a dramatic effect on quality of life and is in-
creasing in all countries. Numerous studies in different coun-
tries around the world have reported that the prevalence of
ED is very high, ranging between 35-90% in men with dia-
betes [25, 26]. In addition, the prevalence of ED in Iranian
people with diabetes has been performed in several studies,
and the severity of this problem is not the same in different
reports [8, 23, 24, 27].
Also, because of the increasing prevalence of diabetes, espe-
cially at younger ages, it is important to pay more attention to
SD and its risk factors when creating health records and con-
sidering routine care for these patients. We aimed to calcu-
late the combined prevalence of erectile dysfunction in Ira-
nian men with diabetes.
2. Methods
This study aimed to assess the prevalence of sexual dysfunc-
tion, more specifically erectile dysfunction in men with dia-
betes in Iran. For this aim, all cross-sectional or baseline data
in cohort studies were included. Keywords such as “sexual
function,” “erectile dysfunction,” “diabetes,” and “Iran” were
searched in international databases including Scopus, Med-
Line, Web of Science, ProQuest, and on the national scien-
tific information database (SID) from inception until October
2020. No language restriction was defined as the studies were
presumed to be published in either English or Farsi. We ex-
cluded studied with non-Iranian participants, experimental
designs, and studies with female participants. Two indepen-
dent researchers completed the process of article selection.
Quality assessment of the studies was performed using the
Newcastle-Ottawa Scale (NOS) checklist [28].
Extracted data included the author‘s information, publica-
tion year, sample size, type of measurement tool, and the es-
timated prevalence of ED. A separate table has been prepared
for the reported related factors for SD. The study outcome
was determined as the proportion of men with diabetes with
SD. To calculate standard error for prevalence estimates, the
exact method and binary distribution were used. Heteroge-
neous Cochrane test (Q) was used to assess the heterogeneity
between studies. The results of this test suggested that the
random-effect model was a perfect strategy for estimating
the pooled prevalence of SD (P<0.001). Forest plot was pre-
pared for prevalence estimation as well as 95% confidence in-
tervals (CIs) so that the size of the squares indicates the spec-
ified weight based on the sample size and vertical lines in-
dicate 95% CI in the estimated prevalence in each study and
the estimated pooled prevalence. Data were analyzed using
Stata software, version 14 (Stata Corp., College Station, TX,
USA).
3. Results
The search retrieved 546 studies at the initial phase. 334 arti-
cles remained after removing duplicates. After title and ab-
stract screening 318 studies were excluded. Ultimately, 11
studies were included in the qualitative synthesis, amongst
which 6 were included for the quantitative synthesis (i.e. cal-
culation of the pooled prevalence) (Figure 1).
The results of the heterogeneity test of the estimated preva-
lence showed a high variation among studies, necessitating
calculation of the pooled prevalence by the random-effects
model (I2=579.91, P<0.001). Accordingly, the pooled preva-
lence of SD across included studies with a total sample size
of 1513 was calculated to be 50.7% (95%CI: 48.0, 52.7%). (Ta-
ble 2)
Risk factors of SD with significant correlation or effect in pa-
tients with diabetes, as shown in table 2 include the duration
of diabetes in 3 (27%) studies, age in 4 (36%) studies, smok-
ing in 2 (18%) studies, obesity and higher body mass index
(BMI) in 2 (18%) studies, lower HDL in 1 (9%) study, hyperc-
holesterolemia in 1 (9%) study, high HbA1c in 2 (18%) stud-
ies, and poor metabolic control in 1 (9%) study. The existence
of other comorbidities such as depression in 4 (36%) studies,
anxiety in 1 (9%) study, stress in 1 (9%) study, hypertension
in 2 (18%) studies, cardiovascular diseases in 2 (18%) stud-
ies was statistically significantly associated with prevalence
of SD. In one study a positive correlation was seen between
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self-efficacy and erectile function. Several studies especially
emphasized the duration of diabetes, and a study calculated
the effect of each year living with diabetes on increasing the
risk of ED by 10% (95% CI 2–18%). Type II diabetes was re-
ported by two studies to have a higher correlation with SD
compared with type I (table 3).
The most common questionnaires used by the included
studies were 15-item International Index for Erectile Func-
tion (IIEF) in 4 (36%) studies, and 5-items IIEF in 3 (27%)
studies, followed by Male Sexual Function Index (MSFI) in
2 (18%) studies, Androgen Deficiency in the Aging Male
(ADAM) in 1 (9%) study, and Sexual Quality of Life-Male
(SQOL-M) in 1 (9%) study.
4. Discussion
The global aging of the world population and increasing inci-
dence of diabetes mellitus may explain the increased preva-
lence of ED in the world [29]. ED is the third most common
complication of diabetes influencing the quality of life [30].
There are a few studies about the prevalence of ED in Iranians
with diabetes mellitus. The prevalence of ED in patients with
diabetes differs across the world, for instances it has been re-
ported to be 35.8% in Italy [31], 64.6% in Japan [32], 65.4% in
Korean [33], 86.1% in Saudi Arabia [34], 38.9% in India [35],
and 71.45% in Africa[36]. In this study, the overall preva-
lence of ED was about 50.7% in Iranian men with diabetes.
the large differences in the reported prevalence of ED in men
with diabetes might be related to differences in methodol-
ogy and population characteristics. The prevalence of ED is
about 18.8% in the Iranian population [37].
The odds of ED in people with diabetes is about 2.69 higher
than the general population in Iran. ED was significantly
higher in men with type II diabetes compared with type I di-
abetes and in older men. These findings are consistent with
the Massachusetts Male Aging Study in which men with di-
abetes showed a threefold chance of having ED compared
with men without diabetes [38]. The results of other high-
quality studies [39] are consistent with our results that ad-
vanced age and Type II diabetes are correlated with an in-
creased risk of ED. In addition, our finding confirmed that de-
pression increased the risk of developing ED in patients with
diabetes mellitus. Regarding the psychological impact of ED,
there was a positive correlation between ED and depression
which contributes to poorer quality of life [40]. ED was as-
sociated with classical cardiovascular risk factors including
smoking, hypertension, hypercholesterolemia, and obesity
in the Iranian population. in a large survey of 7689 men with
diabetes and/or hypertension, ED was reported in 67% of
those with hypertension alone, in 71% with diabetes alone,
and in 77% of men with both diseases [41]. Some studies sug-
gest that ED is a vascular disease [42]. Therefore, ED not only
influences quality of life but is also associated with cardiovas-
cular events in men with diabetes. ED could be considered as
a good predictor of cardiovascular events and all-cause mor-
tality in patients with diabetes mellitus (13). Therefore, early
detection of ED improves both mental and physical health.
Although this study provides valuable information about SD
among men with diabetes in Iran but has some limitations.
First, most studies considered the prevalence of ED in men
with diabetes mellitus and did not separate those with type I
and II diabetes. Second, most studies did not provide com-
plete data. This study showed that there is a link between ED
and cardiovascular risk factors and depressive mood in pa-
tients with diabetes which has an impact on the quality of life
and cardiovascular events. Both psychosocial support and
health care support are crucial for men with diabetes melli-
tus. Future prospective, longitudinal, and separate studies in
both populations with type I and type II diabetes, are encour-
aged to be done.
5. Conclusion
Despite a remarkable heterogeneity among studies on the as-
sociation of diabetes with SD, our analysis showed that more
than half of the Iranian men with diabetes suffer from SD.
Apart from advanced age, the most important attributes for
comorbidity of diabetes and SD in these patients were found
to be chronic uncontrolled high blood sugar and depression.
More advanced epidemiological studies such as prospective
population-based cohort studies are warranted to assess the
temporality of the relationship between SD and its related co-
morbidities and to develop proper preventive programs.
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Table 1: Description of the included studies for qualitative synthesis
First author [reference
number]




Study type ED & Risk factors
Mofid (2009) [23] Sina Hospital (Tehran city), men with
diabetic aged 20-69 years, IIEF
700 Cross-
sectional
A positive association between ED and
duration of diabetes, advanced ages, smoking
status, and poor metabolic control regimen,
Type I DM<Type II DM




ED is associated with higher HbA1C, severer
depression, and lower HDL. No significant
relationship between ED and smoking and
HTN
Mirzaei (2012) [43] Isfahan, men with diabetes aged over
30 years, ADAM questionnaire
243 Cross-
sectional
No correlation between obesity, age, BMI,
HTN, duration of diabetes, smoking & HbA1c &
prevalence of hypogonadism
Ziaei rad (2010) [44] Isfahan, patients with diabetes aged
over 30 years, IIEF 200 Cross-sectional
No association between ED and the
duration of diabetes, diabetes status
and HTN. Type I DM<Type II DM Shiri
(2006) [45] Hamedan, men with




ED was associated with Age, duration of
diabetes, CVD, depression. A non-significant
higher risk of ED was found in current smokers
and in patients with diabetes type 1
Sharifi (2012) [46] Zanjan, Type-II men with diabetes




A negative significant correlation was found
between potency score & age, HbA1c and the
level of fasting blood sugar. History of smoking
did not have predictive value for ED
Rahimi (2018) [47] Kermanshah, men with type II




A negative relationship between sexual




Tehran, infertile men, IIEF 270 Cross-
sectional
Positive association of Age and BMI with sexual
function
Safarinejad (2003) [37] Nationwide, general population of






Positive association of ED with HTN and
diabetes type II, and taking antidepressants,
compared with non-smokers, the OR of ED
was 2.41 (95% CI, 1.52–3.30)
Ghodrati (2018) [24] Karaj, men with diabetes with a
disease duration of >5 years, MSFI
99 Cross-
sectional
Positive association of duration of DM with
decreased sexual function
Bahar (2020) [49] Sari, men with type II diabetes aged
over 20 years, IIEF
350 Cross-
sectional
Lower scores of IIEF was associated with HTN
and Age>50y
IIEF: International index erectile function questionnaire, ADAM: Androgen Deficiency in the Aging Male,
ED: erectile dysfunction, DM: Diabetes Mellitus,
IIEF-5: Short form of International Index of Erectile Function, HTN: hypertension, CVD: Cardiovascular Disease,
MSFI: Male sexual function index, SQOL-M: Sexual Quality of Life-Male, HbA1C: Hemoglobin A1C
Table 2: General description of the studies included into the quantitative synthesis.
Author (year of publi-
cation)
Study Location (city) Sample size Estimated prevalence
(%)
95%CI (%) Weight
Mofid (2009)[23] Tehran 700 35.0 32.0, 37.0 46.27
Habibi (2011)[27] Birjand 171 65.5 58.0, 72.0 11.30
Mirzaei (2012)[43] Isfahan 243 86.8 82.0, 90.0 16.06
Ziaei-Raad (2010)[44] Isfahan 100 14.0 7.0, 20.0 6.61
Sharifi (2012)[46] Zanjan 200 59.0 52.0, 65.0 13.22
Ghodrati (2018)[24] Karaj 99 67.0 57.0, 76.0 6.54
Pooled prevalence 1513 50.7 48.7, 52.7 100.00
Heterogeneity statistic Degrees of freedom p-value I2
Test of heterogeneity 579.91 5 <0.001 99.1%
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Table 3: Estimated association between selected factors/exposures with prevalence of sexual dysfunction among Iranian men.
Factor Frequency (%) of the reported association
Significant association Non-significant association
Advanced age 4 (80%) 1 (20%)
Duration of diabetes 3(60%) 2 (40%)
Tobacco smoking 2(33%) 4 (67%)
Diabetes type II 2(66%) 1 (33%)
Hypertension 2 (50%) 2 (50%)
Higher values of HbA1C 2(66%) 1 (33%)
Low HDL 1(50%) 1(50%)
Depression 4 (100%) 0 (0%)
Cardiovascular diseases 2 (100%) 0 (0%)
High BMI (BMI>30) 1(50%) 1(50%)
Hypercholesterolemia 1 (100%) 0 (0%)
Poor self-efficacy 1 (100%) 0 (0%)
Poor glycemic control 1 (100%) 0 (0%)
Higher triglyceride 0 (0%) 1 (100%)
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Figure 1: PRISMA Flow diagram of studies on sexual dysfunction in diabetic Iranian men.
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Figure 2: Forest plot for the meta-analysis of the prevalence of sexual dysfunction among patients with diabetic in Iran.
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